In fact, interesting recent work identified that inhibitors against Bromodomain Containing 4 (BRD4) downregulate FSP1 thereby sensitizing DLBCL cells to ferroptosis [39]. The gene discussed is AIFM2; the disease is diffuse large B-cell lymphoma.